Home/Filings/4/0001209191-08-020303

4//SEC Filing

DELEAGE JEAN 4

Accession 0001209191-08-020303

CIK 0001088856other

View on SEC.gov Company Profile

Filed

Mar 25, 8:00 PM ET

Accepted

Mar 26, 5:53 PM ET

Size

20.2 KB

Accession

0001209191-08-020303

Insider Transaction Report

Form 4

Period: 2008-03-25

CORCEPT THERAPEUTICS INCCORT

ALTA EMBARCADERO PARTNERS II LLC

10% Owner

Transactions

Purchase
Common Stock
2008-03-25$2.77/sh+13,214$36,603→ 166,491 total(indirect: By Fund)
Purchase
Warrant
2008-03-25$0.13/sh+6,607$826→ 6,607 total(indirect: By Fund)
Exercise: $2.77From: 2008-03-25Exp: 2015-03-25→ Common (6,607 underlying)
Purchase
Common Stock
2008-03-25$2.77/sh+1,045,921$2,897,201→ 5,043,299 total(indirect: By Fund)
Purchase
Warrant
2008-03-25$0.13/sh+522,960$65,370→ 522,960 total(indirect: By Fund)
Exercise: $2.77From: 2008-03-25Exp: 2015-03-25→ Common (522,960 underlying)

CHAMPSI FARAH

10% Owner

Transactions

Purchase
Warrant
2008-03-25$0.13/sh+522,960$65,370→ 522,960 total(indirect: By Fund)
Exercise: $2.77From: 2008-03-25Exp: 2015-03-25→ Common (522,960 underlying)
Purchase
Warrant
2008-03-25$0.13/sh+6,607$826→ 6,607 total(indirect: By Fund)
Exercise: $2.77From: 2008-03-25Exp: 2015-03-25→ Common (6,607 underlying)
Purchase
Common Stock
2008-03-25$2.77/sh+1,045,921$2,897,201→ 5,043,299 total(indirect: By Fund)
Purchase
Common Stock
2008-03-25$2.77/sh+13,214$36,603→ 166,491 total(indirect: By Fund)

ALTA PARTNERS II INC

10% Owner

Transactions

Purchase
Common Stock
2008-03-25$2.77/sh+13,214$36,603→ 166,491 total(indirect: By Fund)
Purchase
Warrant
2008-03-25$0.13/sh+6,607$826→ 6,607 total(indirect: By Fund)
Exercise: $2.77From: 2008-03-25Exp: 2015-03-25→ Common (6,607 underlying)
Purchase
Common Stock
2008-03-25$2.77/sh+1,045,921$2,897,201→ 5,043,299 total(indirect: By Fund)
Purchase
Warrant
2008-03-25$0.13/sh+522,960$65,370→ 522,960 total(indirect: By Fund)
Exercise: $2.77From: 2008-03-25Exp: 2015-03-25→ Common (522,960 underlying)

DELEAGE JEAN

10% Owner

Transactions

Purchase
Common Stock
2008-03-25$2.77/sh+13,214$36,603→ 166,491 total(indirect: By Fund)
Purchase
Warrant
2008-03-25$0.13/sh+522,960$65,370→ 522,960 total(indirect: By Fund)
Exercise: $2.77From: 2008-03-25Exp: 2015-03-25→ Common (522,960 underlying)
Purchase
Warrant
2008-03-25$0.13/sh+6,607$826→ 6,607 total(indirect: By Fund)
Exercise: $2.77From: 2008-03-25Exp: 2015-03-25→ Common (6,607 underlying)
Purchase
Common Stock
2008-03-25$2.77/sh+1,045,921$2,897,201→ 5,043,299 total(indirect: By Fund)

ALTA CALIFORNIA MANAGEMENT PARTNERS II LLC

10% Owner

Transactions

Purchase
Common Stock
2008-03-25$2.77/sh+1,045,921$2,897,201→ 5,043,299 total(indirect: By Fund)
Purchase
Warrant
2008-03-25$0.13/sh+522,960$65,370→ 522,960 total(indirect: By Fund)
Exercise: $2.77From: 2008-03-25Exp: 2015-03-25→ Common (522,960 underlying)
Purchase
Warrant
2008-03-25$0.13/sh+6,607$826→ 6,607 total(indirect: By Fund)
Exercise: $2.77From: 2008-03-25Exp: 2015-03-25→ Common (6,607 underlying)
Purchase
Common Stock
2008-03-25$2.77/sh+13,214$36,603→ 166,491 total(indirect: By Fund)

ALTA BIOPHARMA PARTNERS II LP

10% Owner

Transactions

Purchase
Warrant
2008-03-25$0.13/sh+522,960$65,370→ 522,960 total(indirect: By Fund)
Exercise: $2.77From: 2008-03-25Exp: 2015-03-25→ Common (522,960 underlying)
Purchase
Common Stock
2008-03-25$2.77/sh+1,045,921$2,897,201→ 5,043,299 total(indirect: By Fund)
Purchase
Common Stock
2008-03-25$2.77/sh+13,214$36,603→ 166,491 total(indirect: By Fund)
Purchase
Warrant
2008-03-25$0.13/sh+6,607$826→ 6,607 total(indirect: By Fund)
Exercise: $2.77From: 2008-03-25Exp: 2015-03-25→ Common (6,607 underlying)

Footnotes (3)

[F1]These securities are held by Alta BioPharma Partners II, L.P. ("ABPII").
[F2]Alta Partners II, Inc. ("APII") provides investment advisory services to ABPII and Alta Embarcadero BioPharma Partners II, LLC ("AEBPII" and, along with ABPII, the "Funds"). Jean Deleage, Alix Marduel and Farah Champsi (collectively, the "Principals") are managing directors of Alta BioPharma Management II, LLC ("ABMII"), which is the general partner of ABPII, and the managers of AEBPII. Ms. Marduel is a director of the Issuer and files separate Section 16 reports. The Principals may be deemed to share voting and investment power over the shares held by the Funds. Each of the Reporting Persons disclaims beneficial ownership of all such shares held by the Funds, except to the extent of his, her or its proportionate pecuniary interest therein.
[F3]These securities are held by AEBPII.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

CORCEPT THERAPEUTICS INC

CIK 0001088856

→

Entity typeother

Related Parties

filerCIK 0001198323

Filing Metadata

Form type: 4
Filed: Mar 25, 8:00 PM ET
Accepted: Mar 26, 5:53 PM ET
Size: 20.2 KB

View on SEC.gov